A Population‐Based Intervention to Improve Care Cascades of Patients With Hepatitis C Virus Infection
John Scott, Meaghan Fagalde, Atar Baer, Sara Glick, Elizabeth Barash, Hilary Armstrong, Kris V. Kowdley, Matthew R. Golden, Alexander J. Millman, Noele P. Nelson, Lauren Canary, Matthew Messerschmidt, Pallavi Patel, Michael Ninburg, Jeff Duchin – 7 November 2020 – Hepatitis C virus (HCV) infection is common in the United States and leads to significant morbidity, mortality, and economic costs. Simplified screening recommendations and highly effective direct‐acting antivirals for HCV present an opportunity to eliminate HCV.